Asensus Surgical (ASXC) Financials

$0.35

$0.00 (0.60%)

As on 22-Aug-2024 09:30EDT

Market cap

$95 Mln

Revenue (TTM)

$10 Mln

P/E Ratio

--

P/B Ratio

7.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	9.85	8.58	7.09	8.23	3.18	8.53
Cost of Revenue	13.19	13.61	10.87	11.10	5.17	20.73
Gross Profit	-3.34	-5.03	-3.79	-2.86	-1.99	-12.20
Operating Expenses	67.77	73.10	71.58	63.32	54.62	79.54
Operating Profit (EBIT)	-71.11	-78.13	-75.68	-64.62	-60.39	-154.58
Other Income	--	--	0.85	2.75	-0.42	--
Profit before Tax	-83.44	-78.12	-75.24	-62.24	-60.83	-157.33
Provision for Tax	0.36	0.31	0.32	0.23	-1.52	-3.12
Profit after Tax (Net Income)	-83.80	-78.43	-75.56	-62.46	-59.31	-154.20
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-75.56	-62.46	-60.02	-154.20

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	-11.33	33.41	99.65	169.25	61.57	55.54
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	9.91	14.49	5.99	7.38	6.41	6.22
Current Liabilities	39.92	12.63	10.41	9.85	10.28	13.02
Total Liabilities	78.42	60.53	116.05	186.47	78.26	74.78

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	19.06	24.15	29.18	73.18	44.25	46.82
Current Assets	19.44	36.39	86.87	113.30	34.01	27.96
Total Assets	78.42	60.53	116.05	186.47	78.26	74.78
Total Debt*	20.43	5.68	5.54	5.69	2.82	1.11
Net Current Assets	-20.48	23.76	76.46	103.45	23.73	14.93

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-63.63	-58.94	-40.66	-46.68	-73.48
Cash Flow from Investing Activities	--	--	47.54	-119.67	0.00	67.65
Cash from Financing Activities	--	9.63	-0.33	161.71	53.37	-5.61
Net Cash Inflow / Outflow	--	--	-11.73	1.38	6.69	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-0.32	-0.31	-0.32	-0.28	-0.84	-8.57
Cash EPS ($)	--	-0.30	-0.27	-0.21	-0.64	-7.87
Adjusted Book Value ($)	--	0.13	0.42	0.75	0.87	3.09
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.25	-0.25	-0.18	-0.66	-4.08
Free Cash Flow per Share ($)	--	-0.26	-0.26	-0.19	-0.66	-4.11

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-108.72	-53.95	-52.20	-98.01	-121.37
ROE (%)	--	-117.89	-56.20	-54.12	-101.30	-137.65
ROA (%)	-100.09	-88.83	-49.95	-47.19	-77.51	-98.19
EBIT Margin (%)	-721.18	-910.92	-1,051.46	-781.07	-1,785.76	-1,811.92
Net Margin (%)	-850.75	-914.46	-952.49	-568.66	-2,152.89	-1,807.54
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	39.05	0.21	-0.14	1.59	-0.63	-0.65
EBIT Growth (%)	9.04	-4.85	-15.89	-13.40	63.32	-150.02
Net Profit Growth (%)	-3.84	-3.80	-20.97	-5.31	61.54	-149.61
EPS Growth (%)	4.87	0.02	-0.16	0.67	0.90	-1.22
Book Value Growth (%)	-116.25	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-1.02	-1.09	-4.03	-0.75	-0.17
Price / Book Value	7.09	2.39	0.83	1.49	0.72	0.48
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.78	-0.87	-0.28	-3.17	-0.72	-0.23
Close Price ($)	0.33	0.32	0.35	1.11	0.63	1.47
High Price ($)	0.65	1.18	1.22	6.95	2.62	43.29
Low Price ($)	0.20	0.20	0.28	0.65	0.28	1.35
Market Cap ($ Cr)	94.92	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.17	0.06	0.03	0.05	0.02
Short term debt to equity ratio	-1.45	0.03	0.01	0.00	0.02	0.02
Current Ratio	0.49	2.88	8.34	11.50	3.31	2.15
Quick Ratio	0.31	2.31	7.55	10.63	2.33	1.33
Interest Coverage	-122.25	-2,604.33	-181.75	-173.78	-2,984.11	-33.51

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	4.12	40.90	39.65	25.02	35.12	7.27
Asset Turnover	0.12	0.10	0.05	0.06	0.04	0.05
Receivable days	--	134.53	125.50	70.44	99.80	197.07
Inventory Days	--	207.43	284.18	307.25	731.31	190.23
Payable days	--	100.56	114.16	89.09	195.99	70.58
Cash Conversion Cycle	--	241.39	295.52	288.60	635.12	316.72

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.